Separation of anti-angiogenic and cytotoxic activities of borrelidin by modification at the C17 side chain.
Barrie Wilkinson, Matthew A Gregory, Steven J Moss, Isabelle Carletti, Rose M Sheridan, Andrew Kaja, Michael Ward, Carlos Olano, Carmen Mendez, José A Salas, Peter F Leadlay, Rob vanGinckel, Ming-Qiang Zhang
Index: Bioorg. Med. Chem. Lett. 16 , 5814-7, (2006)
Full Text: HTML
Abstract
A set of novel borrelidin analogues have been prepared by precursor-directed biosynthesis. Structure-activity relationship analysis suggests that steric structural arrangement within the C17 side chain is important for differentiating cytotoxic and anti-angiogenic activities. A C17-cyclobutyl analogue 3 was found to have markedly increased selectivity for in vitro angiogenesis inhibition over cytotoxicity and is therefore potentially useful as an anticancer agent.
Related Compounds
Related Articles:
2011-04-01
[Antimicrob. Agents Chemother. 55(4) , 1784-6, (2011)]
Total synthesis of borrelidin.
2007-04-13
[J. Org. Chem. 72 , 2744, (2007)]
2006-08-25
[Chemistry 12(25) , 6684-91, (2006)]
2011-05-01
[J. Antibiot. 64(5) , 381-4, (2011)]
Biosynthesis of the angiogenesis inhibitor borrelidin: directed biosynthesis of novel analogues.
2006-06-14
[Chem. Commun. (Camb.) (22) , 2341-3, (2006)]